Active Surveillance

Active surveillance is considered a treatment option if a cancer is not causing any symptoms and is expected to grow slowly. In the past this approach was mainly suggested to elderly men, or men with serious health problems; however, younger men have started to consider this treatment option. Since prostate cancer often spreads very slowly, many men who have the disease may never require treatment. In many men, it is a means of delaying or deferring therapy and potential quality of life changes associated with current treatment options. Typically, patients on an active surveillance program undergo regular PSA measurements and periodic prostate biopsies to ensure that the cancer is not becoming more aggressive. If there is a change in the prostate cancer then the patient can make a decision to undergo active treatment with either surgery or radiation. Approximately 30% of cancers will progress within 5 years. The intent of active surveillance is curative.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Pars for Prostate fundraiser: September 22, 2022

The First Annual Pars for Prostate golf fundraiser in support of Prostate Cancer Foundation BC takes place September 22, 2022 at Westwood Plateau Golf Course. For information and to register please visit www.parsforprostate.ca

Dr. Black

Terry Fox Run fundraiser: September 18th, 2022

The 42nd Annual Terry Fox Run is taking place on Sunday September 18, 2022. If you are able, please consider joining and/or donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research

Employment

Work at the Vancouver Prostate Centre

Tuesday, September 20, 2022

Dr Mads Daugaard develops an AI cell analytics app which could supercharge biotechnology research

Wednesday, July 20, 2022

With just a tablespoon of blood, B.C. researchers aim to transform cancer treatment